Tag Archives: drug

Essential Reads: SBIRT for Women with Alcohol and Drug Use During Pregnancy

Critical to the wellbeing of pregnant women and their infants is universal screening for drug and alcohol use. This is an essential first step in identifying women with harmful substance use and connecting them with appropriate services.  Screening, Brief Intervention and Referral to Treatment or SBIRT has been shown to be a quick and effective… Read More »

In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug

Advertisement Continue reading the main story Supported by Continue reading the main story In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. Now it recommends that the drug be given only to those with mild symptoms. A patient received an infusion of… Read More »

U.S. Food and Drug Administration Approves New Formulation of Epclusa, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C

FOSTER CITY, Calif.–(BUSINESS WIRE)–Jun. 10, 2021– Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved an expansion of the pediatric indication of Epclusa (sofosbuvir/velpatasvir) for the treatment of chronic hepatitis C virus (HCV) to now include children as young as 3 years of age, regardless of HCV… Read More »

Transparency by drug companies, scrutiny by journalists, vital in vaccine news

Pfizer’s chairman and CEO proclaimed in a Pfizer company news release: “Today is a great day for science and humanity.” In that PR news release – but only in that format – Pfizer announced early results of “a vaccine efficacy rate above 90%, at 7 days after the second dose.” That’s about all we know… Read More »

Controversial Alzheimer’s Drug Faces Critical Test Before F.D.A. Panel

A federal panel will decide on Friday whether to recommend approval of a controversial but potentially promising Alzheimers drug, which would be the first to come to market in nearly two decades. The drug, aducanumab, would not stop or reverse dementia, but some evidence suggests it can slow the progression of memory and thinking problems… Read More »

Drug being tested for at-home treatment in hopes of slowing virus

Researchers at Beth Israel Deaconess Medical Center are testing a new approach to fighting COVID-19, using a repurposed antiviral AIDS drug for at-home treatment during the first days of symptoms in hopes of slowing the virus early and heading off hospitalization, intensive care, and death. The nationwide clinical trial is being led by Nathan Shapiro,… Read More »